Cytosorbents Corp Accounts Receivable, after Allowance for Credit Loss, Current
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $6.79M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $7.15M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $7.55M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $7.43M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.79M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $7.15M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $7.55M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $7.43M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $7.74M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $7.67M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $7.32M 10-K · filed 2026-03-30 | $7.32M 10-K · filed 2025-03-31 |
| 2024-09-30 | $6.63M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $7.82M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $6.77M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $6.06M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $6.18M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $7.02M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $5.53M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $5.66M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $4.96M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $5.17M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $4.58M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $4.52M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $5.24M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $5.75M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $5.02M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $5.16M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $5.80M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $3.89M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $5.40M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $4.47M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $3.45M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $3.45M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $3.27M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $3.94M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $3.64M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $2.90M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $2.35M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $2.21M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $2.35M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.06M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $1.73M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $1.43M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $1.41M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $944.78K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $760.16K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $648.87K 10-K · filed 2017-03-03 | |
| 2015-09-30 | $553.38K 10-Q · filed 2015-11-13 | |
| 2014-12-31 | $819.15K 10-K · filed 2016-03-09 | |
| 2012-03-31 | $39.79K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $36.08K 10-Q · filed 2012-05-15 |